Literature DB >> 28330863

Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Henry L Schreiber1,2, Matt S Conover1, Wen-Chi Chou2, Michael E Hibbing1, Abigail L Manson2, Karen W Dodson1, Thomas J Hannan3, Pacita L Roberts4, Ann E Stapleton4, Thomas M Hooton5, Jonathan Livny6, Ashlee M Earl6, Scott J Hultgren7,8.   

Abstract

Urinary tract infections (UTIs) are caused by uropathogenic Escherichia coli (UPEC) strains. In contrast to many enteric E. coli pathogroups, no genetic signature has been identified for UPEC strains. We conducted a high-resolution comparative genomic study using E. coli isolates collected from the urine of women suffering from frequent recurrent UTIs. These isolates were genetically diverse and varied in their urovirulence, that is, their ability to infect the bladder in a mouse model of cystitis. We found no set of genes, including previously defined putative urovirulence factors (PUFs), that were predictive of urovirulence. In addition, in some patients, the E. coli strain causing a recurrent UTI had fewer PUFs than the supplanted strain. In competitive experimental infections in mice, the supplanting strain was more efficient at colonizing the mouse bladder than the supplanted strain. Despite the lack of a clear genomic signature for urovirulence, comparative transcriptomic and phenotypic analyses revealed that the expression of key conserved functions during culture, such as motility and metabolism, could be used to predict subsequent colonization of the mouse bladder. Together, our findings suggest that UTI risk and outcome may be determined by complex interactions between host susceptibility and the urovirulence potential of diverse bacterial strains.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28330863      PMCID: PMC5653229          DOI: 10.1126/scitranslmed.aaf1283

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  87 in total

1.  Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups.

Authors:  Matija Rijavec; Marjanca Starcic Erjavec; Jerneja Ambrozic Avgustin; Rolf Reissbrodt; Angelika Fruth; Veronika Krizan-Hergouth; Darja Zgur-Bertok
Journal:  Curr Microbiol       Date:  2006-06-26       Impact factor: 2.188

Review 3.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

4.  Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis.

Authors:  James R Johnson; Stephen Porter; Brian Johnston; Michael A Kuskowski; Rachel R Spurbeck; Harry L T Mobley; Deborah A Williamson
Journal:  Open Forum Infect Dis       Date:  2015-06-06       Impact factor: 3.835

5.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

Review 6.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

7.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.

Authors:  X R Wu; T T Sun; J J Medina
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli.

Authors:  J Parkkinen; G N Rogers; T Korhonen; W Dahr; J Finne
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 9.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

10.  Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains.

Authors:  François Lebreton; Willem van Schaik; Abigail Manson McGuire; Paul Godfrey; Allison Griggs; Varun Mazumdar; Jukka Corander; Lu Cheng; Sakina Saif; Sarah Young; Qiandong Zeng; Jennifer Wortman; Bruce Birren; Rob J L Willems; Ashlee M Earl; Michael S Gilmore
Journal:  mBio       Date:  2013-08-20       Impact factor: 7.867

View more
  52 in total

Review 1.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 2.  Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Authors:  Roger D Klein; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2020-02-18       Impact factor: 60.633

3.  Bacterial Pathogenesis: What makes some E. coli efficient bladder colonizers?

Authors:  Ursula Hofer
Journal:  Nat Rev Microbiol       Date:  2017-04-10       Impact factor: 60.633

4.  Reflections on the void: the art of micturition analysis.

Authors:  Bisiayo E Fashemi; Indira U Mysorekar
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-10

5.  Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients.

Authors:  Krystal J Thomas-White; Xiang Gao; Huaiying Lin; Cynthia S Fok; Kathryn Ghanayem; Elizabeth R Mueller; Qunfeng Dong; Linda Brubaker; Alan J Wolfe
Journal:  Int Urogynecol J       Date:  2018-09-28       Impact factor: 2.894

Review 6.  Engineering bacteria for diagnostic and therapeutic applications.

Authors:  David T Riglar; Pamela A Silver
Journal:  Nat Rev Microbiol       Date:  2018-02-05       Impact factor: 60.633

7.  Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.

Authors:  Valerie P O'Brien; Matthew S Joens; Amanda L Lewis; Nicole M Gilbert
Journal:  J Vis Exp       Date:  2020-12-04       Impact factor: 1.355

8.  Characteristics of the microbiota in the urine of women with type 2 diabetes.

Authors:  Sue Penckofer; Robert Limeira; Cara Joyce; Meghan Grzesiak; Krystal Thomas-White; Alan J Wolfe
Journal:  J Diabetes Complications       Date:  2020-03-03       Impact factor: 2.852

9.  Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities.

Authors:  Allison R Eberly; Connor J Beebout; Ching Man Carmen Tong; Gerald T Van Horn; Hamilton D Green; Madison J Fitzgerald; Shuvro De; Emily K Apple; Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean; Douglass B Clayton; Charles W Stratton; Jonathan E Schmitz; Maria Hadjifrangiskou
Journal:  J Mol Biol       Date:  2019-11-30       Impact factor: 5.469

10.  Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection.

Authors:  Lena M Biehl; Rebeca Cruz Aguilar; Fedja Farowski; Werner Hahn; Angela Nowag; Hilmar Wisplinghoff; Maria J G T Vehreschild
Journal:  Infection       Date:  2018-08-14       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.